Disclosures for "Vormatrigine Rapidly Reduces Seizures in Adults with Treatment-resistant Epilepsy: Results from the RADIANT Study"
-
Dr. Hansen has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Mohsen has nothing to disclose.
-
Dr. Epstein has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Ms. Hernandez has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Megan Sniecinski has received personal compensation for serving as an employee of Praxis Precision Medicines. Megan Sniecinski has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Praxis Precision Medicines.
-
Dr. Crimin has received personal compensation for serving as an employee of Praxis Precision Medicine. Dr. Crimin has received personal compensation for serving as an employee of Biohaven. Dr. Crimin has stock in Biohaven. Dr. Crimin has stock in Praxis Precision Medicine.
-
Miss Tang has nothing to disclose.
-
Dr. Petrou has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Petrou has stock in Praxis Precision Medicines. The institution of Dr. Petrou has received research support from Praxis Precision Medicines. Dr. Petrou has received intellectual property interests from a discovery or technology relating to health care.
-
Marcio Souza has received personal compensation for serving as an employee of Praxis Precision Medicines.
-
Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
-
Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Angelini. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke pharma. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz pharma. Angel Aledo-Serrano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB.